21st century innovations in cutting-edge technologies have led to discovery of novel genetic, immunological and cell biological mechanisms underlying biology and parthenogenesis of different diseases including cancer. A special revolution has been made by this in diagnosis, prognosis and treatment of hematological malignancies specifically leukemias and lymphomas. Many molecular and immunological biomarkers have been discovered and utilized as drug targets to develop targeted molecular therapies in this regard. These efforts have specifically revolutionized clinically management of Chronic Myeloid Leukemia which has been transformed from a fatal disease to "almost-cured' cancer in first quarter of 21st century. Nevertheless, due to devil dynamic nature of cancer as a disease, there are still many challenges in CML prognosis and treatment. This book provides an account of molecular pathogenesis as well as current and prospective targeted therapies in CML. It also highlights some missing lessons and challenges in diagnosis, prognostic stratification, treatment monitoring, drug resistance and treatment-free remission of CML as well as major focus areas in CML treatment and research.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -21st century innovations in cutting-edge technologies have led to discovery of novel genetic, immunological and cell biological mechanisms underlying biology and parthenogenesis of different diseases including cancer. A special revolution has been made by this in diagnosis, prognosis and treatment of hematological malignancies specifically leukemias and lymphomas. Many molecular and immunological biomarkers have been discovered and utilized as drug targets to develop targeted molecular therapies in this regard. These efforts have specifically revolutionized clinically management of Chronic Myeloid Leukemia which has been transformed from a fatal disease to 'almost-cured' cancer in first quarter of 21st century. Nevertheless, due to devil dynamic nature of cancer as a disease, there are still many challenges in CML prognosis and treatment. This book provides an account of molecular pathogenesis as well as current and prospective targeted therapies in CML. It also highlights some missing lessons and challenges in diagnosis, prognostic stratification, treatment monitoring, drug resistance and treatment-free remission of CML as well as major focus areas in CML treatment and research. 72 pp. Englisch. N° de réf. du vendeur 9786202679954
Quantité disponible : 2 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - 21st century innovations in cutting-edge technologies have led to discovery of novel genetic, immunological and cell biological mechanisms underlying biology and parthenogenesis of different diseases including cancer. A special revolution has been made by this in diagnosis, prognosis and treatment of hematological malignancies specifically leukemias and lymphomas. Many molecular and immunological biomarkers have been discovered and utilized as drug targets to develop targeted molecular therapies in this regard. These efforts have specifically revolutionized clinically management of Chronic Myeloid Leukemia which has been transformed from a fatal disease to 'almost-cured' cancer in first quarter of 21st century. Nevertheless, due to devil dynamic nature of cancer as a disease, there are still many challenges in CML prognosis and treatment. This book provides an account of molecular pathogenesis as well as current and prospective targeted therapies in CML. It also highlights some missing lessons and challenges in diagnosis, prognostic stratification, treatment monitoring, drug resistance and treatment-free remission of CML as well as major focus areas in CML treatment and research. N° de réf. du vendeur 9786202679954
Quantité disponible : 1 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Iqbal ZafarDr Zafar Iqbal obtained his PhD in molecular pathogenesis and pharmacogenomics of hematological malignancies and postdoctoral fellowship in pre-clinical drug testing of leukemia. He has published his research in various IS. N° de réf. du vendeur 494631254
Quantité disponible : Plus de 20 disponibles
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -21st century innovations in cutting-edge technologies have led to discovery of novel genetic, immunological and cell biological mechanisms underlying biology and parthenogenesis of different diseases including cancer. A special revolution has been made by this in diagnosis, prognosis and treatment of hematological malignancies specifically leukemias and lymphomas. Many molecular and immunological biomarkers have been discovered and utilized as drug targets to develop targeted molecular therapies in this regard. These efforts have specifically revolutionized clinically management of Chronic Myeloid Leukemia which has been transformed from a fatal disease to 'almost-cured' cancer in first quarter of 21st century. Nevertheless, due to devil dynamic nature of cancer as a disease, there are still many challenges in CML prognosis and treatment. This book provides an account of molecular pathogenesis as well as current and prospective targeted therapies in CML. It also highlights some missing lessons and challenges in diagnosis, prognostic stratification, treatment monitoring, drug resistance and treatment-free remission of CML as well as major focus areas in CML treatment and research.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 72 pp. Englisch. N° de réf. du vendeur 9786202679954
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Genetic pathogenesis and targeted therapy in Chronic Myeloid Leukemia | Missing lessons and current challenges in diagnosis, prognosis and treatment of CML in post-imatinib cancer therapy era | Zafar Iqbal (u. a.) | Taschenbuch | Englisch | 2020 | LAP LAMBERT Academic Publishing | EAN 9786202679954 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand. N° de réf. du vendeur 120447796
Quantité disponible : 5 disponible(s)